138 related articles for article (PubMed ID: 26136736)
1. A transient resistance to blood-stage malaria in interferon-γ-deficient mice through impaired production of the host cells preferred by malaria parasites.
Okada H; Suzue K; Imai T; Taniguchi T; Shimokawa C; Onishi R; Hirata J; Hisaeda H
Front Microbiol; 2015; 6():600. PubMed ID: 26136736
[TBL] [Abstract][Full Text] [Related]
2. Fluctuations of Spleen Cytokine and Blood Lactate, Importance of Cellular Immunity in Host Defense Against Blood Stage Malaria
Imai T; Suzue K; Ngo-Thanh H; Ono S; Orita W; Suzuki H; Shimokawa C; Olia A; Obi S; Taniguchi T; Ishida H; Van Kaer L; Murata S; Tanaka K; Hisaeda H
Front Immunol; 2019; 10():2207. PubMed ID: 31608052
[TBL] [Abstract][Full Text] [Related]
3. Outcome of primary lethal and nonlethal Plasmodium yoelii malaria infection in BALB/c and IFN-γ receptor-deficient mice following chloroquine treatment.
Ishih A; Kawakami C; Todoroki A; Hirai H; Ohori K; Kobayashi F
Parasitol Res; 2013 Feb; 112(2):773-80. PubMed ID: 23180129
[TBL] [Abstract][Full Text] [Related]
4. Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.
Imai T; Shen J; Chou B; Duan X; Tu L; Tetsutani K; Moriya C; Ishida H; Hamano S; Shimokawa C; Hisaeda H; Himeno K
Eur J Immunol; 2010 Apr; 40(4):1053-61. PubMed ID: 20101613
[TBL] [Abstract][Full Text] [Related]
5. Role of IFN-gamma in lethal and nonlethal malaria in susceptible and resistant murine hosts.
Shear HL; Srinivasan R; Nolan T; Ng C
J Immunol; 1989 Sep; 143(6):2038-44. PubMed ID: 2506274
[TBL] [Abstract][Full Text] [Related]
6. Production of interleukin 10 during malaria caused by lethal and nonlethal variants of Plasmodium yoelii yoelii.
Kobayashi F; Morii T; Matsui T; Fujino T; Watanabe Y; Weidanz WP; Tsuji M
Parasitol Res; 1996; 82(5):385-91. PubMed ID: 8738275
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Plasmodium yoelii blood-stage malaria by interferon alpha through the inhibition of the production of its target cell, the reticulocyte.
Vigário AM; Belnoue E; Cumano A; Marussig M; Miltgen F; Landau I; Mazier D; Gresser I; Rénia L
Blood; 2001 Jun; 97(12):3966-71. PubMed ID: 11389041
[TBL] [Abstract][Full Text] [Related]
8. The course of a primary infection of Plasmodium yoelii 17XL in both 129S1 and IFN-γ receptor-deficient mice.
Ishih A; Nagata T; Kobayashi F
Parasitol Res; 2012 Aug; 111(2):593-600. PubMed ID: 22392138
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium vinckei: infectivity of arteether-sensitive and arteether-resistant parasites in different strains of mice.
Chandra R; Kumar S; Puri SK
Parasitol Res; 2011 Oct; 109(4):1143-9. PubMed ID: 21479576
[TBL] [Abstract][Full Text] [Related]
10. Gamma interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical.
Yoneto T; Yoshimoto T; Wang CR; Takahama Y; Tsuji M; Waki S; Nariuchi H
Infect Immun; 1999 May; 67(5):2349-56. PubMed ID: 10225894
[TBL] [Abstract][Full Text] [Related]
11. Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection.
Kobayashi F; Ishida H; Matsui T; Tsuji M
J Vet Med Sci; 2000 Jun; 62(6):583-7. PubMed ID: 10907683
[TBL] [Abstract][Full Text] [Related]
12. Listeria monocytogenes inoculation protects mice against blood-stage Plasmodium yoelii infection.
Qi Z; Han X; Zhang Y; Wang J; Cao YM
Tohoku J Exp Med; 2013 Feb; 229(2):87-96. PubMed ID: 23303295
[TBL] [Abstract][Full Text] [Related]
13. CD47 regulates the phagocytic clearance and replication of the Plasmodium yoelii malaria parasite.
Banerjee R; Khandelwal S; Kozakai Y; Sahu B; Kumar S
Proc Natl Acad Sci U S A; 2015 Mar; 112(10):3062-7. PubMed ID: 25713361
[TBL] [Abstract][Full Text] [Related]
14. In vivo study of toxoplasmic parasitemia using interferon-gamma-deficient mice: absolute cell number of leukocytes, parasite load and cell susceptibility.
Norose K; Naoi K; Fang H; Yano A
Parasitol Int; 2008 Dec; 57(4):447-53. PubMed ID: 18585475
[TBL] [Abstract][Full Text] [Related]
15. The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA.
Singh RP; Kashiwamura S; Rao P; Okamura H; Mukherjee A; Chauhan VS
J Immunol; 2002 May; 168(9):4674-81. PubMed ID: 11971017
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium yoelii: assessment of production and role of nitric oxide during the early stages of infection in susceptible and resistant mice.
Wang QH; Liu YJ; Liu J; Chen G; Zheng W; Wang JC; Cao YM
Exp Parasitol; 2009 Mar; 121(3):268-73. PubMed ID: 19109953
[TBL] [Abstract][Full Text] [Related]
17. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
Scharton-Kersten TM; Wynn TA; Denkers EY; Bala S; Grunvald E; Hieny S; Gazzinelli RT; Sher A
J Immunol; 1996 Nov; 157(9):4045-54. PubMed ID: 8892638
[TBL] [Abstract][Full Text] [Related]
18. Impaired macrophage responses may contribute to exacerbation of blood-stage Plasmodium chabaudi chabaudi malaria in interleukin-12-deficient mice.
Bastos KR; Barboza R; Elias RM; Sardinha LR; Grisotto MG; Marinho CR; Amarante-Mendes GP; Alvarez JM; Lima MR
J Interferon Cytokine Res; 2002 Dec; 22(12):1191-9. PubMed ID: 12581492
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of non-specific protection against murine malaria induced by BCG vaccination.
Parra M; Liu X; Derrick SC; Yang A; Tian J; Kolibab K; Kumar S; Morris SL
PLoS One; 2013; 8(7):e66115. PubMed ID: 23861742
[TBL] [Abstract][Full Text] [Related]
20. Potential and Limitations of Cross-Protective Vaccine against Malaria by Blood-Stage Naturally Attenuated Parasite.
Imai T; Suzue K; Ngo-Thanh H; Shimokawa C; Hisaeda H
Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32664476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
